Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fragmin for chronic neuroischemic diabetic foot ulcers
2007-005784-10Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic foot ulcer (DFU) comparing Fragmin with Placebo (2 arms). Primary endpoint: Ulcer healing response. Started Nov 2007; status: terminated.
02
Drugs
dalteparin
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2007-005784-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005784-10.